ADx NeuroSciences and Alamar Biosciences collaborate to develop tailored biomarker assays for neurological diseases.
ADx NeuroSciences, a Fujirebio subsidiary, has teamed up with Alamar Biosciences to create tailored biomarker assay solutions utilizing Alamar's NULISA™ platform and ARGO™ HT System. This collaboration focuses on enhancing the detection and quantification of biomarkers for neurological diseases like Alzheimer's, Parkinson's, and ALS, aiming to expedite the development of therapies for these conditions.
October 28, 2024
5 Articles